Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 316–316 | Cite as

Sunitinib

RBC count lower than baseline: case report
Case report
  • 4 Downloads

Reference

  1. Kucharz J, et al. Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma. Medical Oncology 33: 109, No. 10, Oct 2016. Available from: URL: http://doi.org/10.1007/s12032-016-0818-9 - Poland

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations